1. Home
  2. CGEM vs BWMX Comparison

CGEM vs BWMX Comparison

Compare CGEM & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BWMX
  • Stock Information
  • Founded
  • CGEM 2016
  • BWMX 1995
  • Country
  • CGEM United States
  • BWMX Mexico
  • Employees
  • CGEM N/A
  • BWMX N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BWMX Catalog/Specialty Distribution
  • Sector
  • CGEM Health Care
  • BWMX Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • BWMX Nasdaq
  • Market Cap
  • CGEM 482.7M
  • BWMX 495.6M
  • IPO Year
  • CGEM 2021
  • BWMX N/A
  • Fundamental
  • Price
  • CGEM $6.45
  • BWMX $13.40
  • Analyst Decision
  • CGEM Strong Buy
  • BWMX Strong Buy
  • Analyst Count
  • CGEM 8
  • BWMX 2
  • Target Price
  • CGEM $27.25
  • BWMX $22.50
  • AVG Volume (30 Days)
  • CGEM 525.8K
  • BWMX 39.2K
  • Earning Date
  • CGEM 11-06-2025
  • BWMX 10-23-2025
  • Dividend Yield
  • CGEM N/A
  • BWMX 10.60%
  • EPS Growth
  • CGEM N/A
  • BWMX N/A
  • EPS
  • CGEM N/A
  • BWMX 0.84
  • Revenue
  • CGEM N/A
  • BWMX $751,432,052.00
  • Revenue This Year
  • CGEM N/A
  • BWMX $6.54
  • Revenue Next Year
  • CGEM N/A
  • BWMX $6.09
  • P/E Ratio
  • CGEM N/A
  • BWMX $16.16
  • Revenue Growth
  • CGEM N/A
  • BWMX 4.83
  • 52 Week Low
  • CGEM $6.44
  • BWMX $7.00
  • 52 Week High
  • CGEM $18.62
  • BWMX $14.46
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 36.01
  • BWMX 58.13
  • Support Level
  • CGEM $6.44
  • BWMX $13.36
  • Resistance Level
  • CGEM $7.82
  • BWMX $13.85
  • Average True Range (ATR)
  • CGEM 0.43
  • BWMX 0.30
  • MACD
  • CGEM -0.11
  • BWMX -0.10
  • Stochastic Oscillator
  • CGEM 4.55
  • BWMX 42.75

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

Share on Social Networks: